Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

226.08 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗

December 06, 2025

This drugmaker has a strong portfolio of best-selling drugs and a growing pipeline.

Via The Motley Fool

Topics ETFs

Could Buying AbbVie Today Set You Up for Life? ↗

December 04, 2025

Don't bet against it.

Via The Motley Fool

Topics Intellectual Property Lawsuit

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Via The Motley Fool

Topics ETFs Stocks

Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny

December 03, 2025

New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN)...

Via MarketMinute

Topics Intellectual Property

2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗

December 02, 2025

These healthcare leaders can make you money while you sleep.

Via The Motley Fool

Topics Artificial Intelligence Cannabis Intellectual Property

3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years ↗

November 29, 2025

These stocks have been raising their dividend payments annually for well over a decade, and they pay more than twice the S&P 500 average.

Via The Motley Fool

Topics Stocks

8 Dividend Stocks Every Investor Should Consider ↗

November 28, 2025

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

Via The Motley Fool

Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗

November 27, 2025

Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries.

Via Stocktwits

Topics ETFs

Exploring the top movers within the S&P500 index during today's session. ↗

November 26, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

1 Surging Stock with Exciting Potential and 2 Facing Challenges

November 25, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Topics Bankruptcy

5 Dividend Stocks to Hold for the Next 10 Years ↗

November 24, 2025

Investors should be able to count on steady dividends from these great stocks.

Via The Motley Fool

Topics Energy Retirement

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy Government World Trade

Unpacking the Latest Options Trading Trends in AbbVie ↗

November 20, 2025

Via Benzinga

If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today ↗

November 19, 2025

Via Benzinga

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Via MarketBeat

Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗

November 19, 2025

Via MarketBeat

3 Cash-Producing Stocks We Think Twice About

November 19, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Derivatives

A Look Into AbbVie Inc's Price Over Earnings ↗

November 17, 2025

Via Benzinga

AbbVie Stock Falls 4% -- What Investors Need to Know ↗

November 17, 2025

It's no reason to stay up at night.

Via The Motley Fool

Topics Intellectual Property

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗

November 17, 2025

Healthcare stocks have far outperformed the broader market over the past month.

Via The Motley Fool

Topics ETFs Government World Trade

These 2 Dividend ETFs Are a Retiree's Best Friend ↗

November 16, 2025

Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.

Via The Motley Fool

Topics Artificial Intelligence Bonds ETFs

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

November 15, 2025

These stocks pay income that investors can count on over the long run.

Via The Motley Fool

Topics Intellectual Property

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors? ↗

November 13, 2025

A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.

Via The Motley Fool

Topics ETFs Economy Retirement

2 Strong Healthcare Stock Picks for Dividend Investors ↗

November 13, 2025

These top dividend payers could enrich a long-term investor's portfolio.

Via The Motley Fool

Topics Economy

AbbVie Shares Rise To Intraday High After Key Trading Signal ↗

November 12, 2025

A key trading signal flashed for AbbVie shares at a price of $228.47, after which ABBV rose as much as 2.4% to an intraday high of $233.90.

Via Benzinga

AbbVie Reportedly Ends Partnership With Alphabet-Backed Calico Life Sciences ↗

November 12, 2025

Stat News reported on Wednesday, citing internal emails, that the move comes amid AbbVie’s shift away from small-molecule drugs, including pills.

Via Stocktwits

Topics Workforce

Mixed Signals on Wall Street: Dow Soars Amidst Government Shutdown Hopes, Tech Giants Stumble

November 12, 2025

New York, NY – November 12, 2025 – The U.S. stock market presented a landscape of diverging fortunes today, as the Dow Jones Industrial Average surged to new record highs, fueled by mounting optimism...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

Dow Soars to All-Time Highs as Nation Awaits Crucial House Vote to End Government Shutdown

November 12, 2025

The Dow Jones Industrial Average (DJIA) has surged to unprecedented levels, marking new all-time highs this week, even as the nation holds its breath for a pivotal vote in the U.S. House of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Three Healthcare Buys That Wall Street Loves ↗

November 11, 2025

These three healthcare stocks are outperforming most of the sector.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions